Skip to main content

Fitzgerald Joseph Michael's Form 4 filing

Boston Scientific Corp (BSX) · filed Dec 14, 2022

Accession no.
0001225208-22-012777
Filed
Dec 14, 2022
Trade date
Jul 29-Dec 13, 2022
Filing delay
138 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $3.79M. It was filed 138 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Fitzgerald Joseph MichaelCIK 0001484186Officer (EVP & Group Pres, Cardiology)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 29, 2022Common StockGGiftDisposed−1,000$0.00$0216,871Direct
Dec 13, 2022Common StockMOption exerciseAcquired+79,264$7.39+$585,760.96296,135Direct
Dec 13, 2022Common StockSSaleDisposed−79,264$47.78−$3,787,233.92216,871Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 13, 2022Common StockMOption exerciseDisposed−79,264$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)